See the evidence of our transition toward a smoke-free future: read these key facts and figures.
Philip Morris International’s value creation model describes what we do and how we allocate our resources to deliver long-term value for both our company and our stakeholders. In 2016, we announced our vision of a smoke-free future and our ambition to accelerate the end of smoking. To achieve this, we are working to replace cigarettes with less harmful tobacco and nicotine products for the benefit of adults who would otherwise continue to smoke.
These facts and figures were most recently updated in April 2023. You can read our latest Integrated Report to learn more about some of these key facts and figures, as well as other performance metrics.
including scientists, engineers, technicians, and support staff working on our smoke-free products in 2022.*
invested in construction of the Cube, PMI's remarkable R&D facility in Neuchâtel, Switzerland.
invested by PMI from 2008 to 2022 in research, product development, production capacity, scientific substantiation, and perception and behavior studies.
including: materials science, consumer electronics, clinical science, and systems toxicology.
total R&D expenditure in 2022.
for smoke-free technologies by the five largest intellectual property offices in the world (IP5, cumulative from 2015 to 2022).**
was dedicated to smoke-free products in 2022.
by PMI from 2008 to 2022 – most open access.
* Data does not include employees of Swedish Match or Vectura Fertin Pharma.
** IP5 jurisdictions are Europe (patents granted by the European Patent Office), China, South Korea, Japan, and the U.S.